Rahul Dua's remark comparing immunotherapy favourably with chemotherapy drew criticism from oncologists online. Doctors said ...

Shanghai is emerging as a favored destination for patients from America and other rich countries who are seeking innovations ...

Early ctDNA changes — tiny pieces of cancer DNA found in the blood — may show whether immunotherapy is working before scans ...

Johnson said he hopes the cell therapy will eventually produce “robust” and “long-lived” effects that extend patients’ life ...

For patients diagnosed with stage 4 cancer, a condition often accompanied by limited treatment options and grim prognoses, immunotherapy offers a new ray of hope. This groundbreaking approach utilizes ...

New research from Dana-Farber Cancer Institute scientists suggests that cyclin-dependent kinase 2 (CDK2) inhibitors, which ...

Few areas of blood cancer treatment have evolved as rapidly as T-cell–based immunotherapy. Chimeric antigen receptor (CAR) ...

Cancer cells can create an antioxidant-rich environment that deprives tumor-fighting T cells of reactive oxygen species, or ROS, which those immune cells need for normal activation and signaling. The ...

Immunotherapy for stage 4 prostate cancer is revolutionizing the way advanced disease is being treated, offering hope for patients worldwide. Unlike conventional treatment methods such as surgery and ...

Immune checkpoint inhibitors, popularized by Allison and Honjo’s Nobel Prize, were one of the first cancer immunotherapies that gained FDA approval. In the 1990s, Allison and Honjo identified the ...

Long-term survivors commonly experience persistent anxiety, and an estimated 20%–30% face increased risks of myocardial infarction and stroke, underscoring the need for structured survivorship care.